MAWA
GILD icon

Moss Adams Wealth Advisors’s Gilead Sciences GILD Stock Holding History

Moss Adams Wealth Advisors’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$677K Buy
4,857
+411
+9% +$57.6K 0.05% 114
2025
Q4 		$546K Buy
4,446
+76
+2% +$9.24K 0.04% 123
2025
Q3 		$485K Buy
4,370
+172
+4% +$19.6K 0.04% 131
2025
Q2 		$465K Buy
4,198
+498
+13% +$53K 0.04% 135
2025
Q1 		$415K Buy
3,700
+586
+19% +$60.5K 0.04% 127
2024
Q4 		$288K Buy
3,114
+555
+22% +$50K 0.03% 151
2024
Q3 		$215K Buy
+2,559
New +$195K 0.02% 187

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Moss Adams Wealth Advisors's GILD Position: Q1 2026 in Review

Moss Adams Wealth Advisors increased its Gilead Sciences (GILD) stake by 9.2% in Q1 2026, buying an estimated $57.6K and bringing the position to 4,857 shares worth $677K. The position accounts for 0.05% of the portfolio, ranked #114.

Moss Adams Wealth Advisors first reported a position in GILD in Q3 2024 and has held it in 7 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Moss Adams Wealth Advisors held 4,857 shares of Gilead Sciences worth $677K as of Q1 2026.
  • Moss Adams Wealth Advisors bought 411 Gilead Sciences shares in Q1 2026, an estimated $57.6K.
  • Gilead Sciences made up 0.05% of Moss Adams Wealth Advisors's portfolio in Q1 2026, its #114 holding.
  • Moss Adams Wealth Advisors first reported a position in Gilead Sciences in Q3 2024 and has held it in 7 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Moss Adams Wealth Advisors's 13F filing for Q1 2026, filed 23 Apr 2026.